Quarterly report which provides a continuing view of a company`s financial position
(WorldNews Japan)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36694 Protara Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 20-4580525 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 1 Little West 12th Street New York, NY (Address of principal executive offices) 10014 (Zip Code) (646) 844-0337...